Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Envoy Medical Receives Positive Listing Determination from NASDAQ
October 27, 2025
Via
Newsfile
Tickers
ASX:COH
COCH
Exposures
Product Safety
Bryan Scott McMillan Calls for Greater Support for Families Facing Grief and Loss
October 24, 2025
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Bio-E Launched Primo Physmo-Bio-E Global Origins in New Zealand
October 24, 2025
Via
Get News
Exposures
Product Safety
Inhibrx Biosciences Soars Over 90% on Breakthrough Rare Bone Cancer Trial Results
October 24, 2025
Via
MarketMinute
Tickers
INBX
Exposures
Product Safety
SNDX Stock Is The Talk Of The Town Today: Here’s Everything To Know About The Latest FDA Approval
October 24, 2025
Via
Stocktwits
Tickers
LABU
SNDX
VHT
Exposures
Product Safety
Wellgistics Health (NASDAQ: WGRX) Soars 168% on Landmark Blockchain Integration for Prescription Tracking
October 24, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Fraud
Tickers
ABC
CAH
DVLT
MCK
WGRX
Exposures
Artificial Intelligence
COVID-19
Legal
CYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline
October 24, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for Investors - Contact Levi & Korsinsky
October 24, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
SVRA
Exposures
Financial
Legal
Product Safety
Lost Money on aTyr Pharma, Inc.(ATYR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
October 24, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
ATYR
Exposures
Financial
Legal
Product Safety
Lost Money on aTyr Pharma, Inc.(ATYR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
October 24, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
ATYR
Exposures
Financial
Legal
Product Safety
Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for Investors - Contact Levi & Korsinsky
October 24, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
SVRA
Exposures
Financial
Legal
Product Safety
InvestorNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Advancing Two-Pronged Approach to Bring Innovative Therapies to Market
October 24, 2025
Via
Investor Brand Network
Tickers
NRXP
Exposures
Product Safety
Marketer.co Releases Comprehensive Healthcare & MedTech Digital Marketing Report for 2025
October 24, 2025
Via
Press Release Distribution Service
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment
October 24, 2025
Via
MarketMinute
Tickers
AGIO
BMY
INBX
NVS
PFE
Exposures
Product Safety
New Research Peptide Supplier Plans Pharmacy Collaborations to Support Licensed Wellness Clinic Sector
October 24, 2025
Via
AB Newswire
Topics
Economy
Supply Chain
Exposures
Product Safety
Supply Chain
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep
October 24, 2025
Via
Benzinga
Tickers
GSK
JNJ
Exposures
Product Safety
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Featured in Channelchek Report Highlighting AVERSA Fentanyl Progress
October 24, 2025
Via
Investor Brand Network
Tickers
NTRB
Exposures
Product Safety
Hillary Clinton Quotes Daughter Chelsea's Attack On Trump For 'Wrecking' The White House, Recalls Why Its Called The 'People's House'
October 24, 2025
Via
Benzinga
Topics
Government
Product Recall
Exposures
Legal
Political
Product Safety
Joshua Sharlin, Ph.D. Launches New Shareholder Lawsuit Expert Witness Service
October 23, 2025
Via
Press Release Distribution Service
Topics
Fraud
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
Harold Skeete Releases New Children’s Book The Monster Proof Blanket Teaching Courage and Brotherly Love
October 23, 2025
Via
Get News
Topics
Bonds
Product Recall
Exposures
Debt Markets
Legal
Product Safety
TechMediaBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) CEO Discusses IzoView Commercialization Strategy in New Departures Capital Interview
October 23, 2025
Via
Investor Brand Network
Tickers
CSE:IZO
IZOZF
Exposures
Product Safety
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
October 23, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Cytokinetics, Incorporated Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
October 23, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
Intelligent Bio Solutions Stock Rises On New Contract For Drug Testing Technology
October 23, 2025
Via
Stocktwits
Topics
Cannabis
Tickers
INBS
VXF
Exposures
Cannabis
Product Safety
3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years
October 23, 2025
Via
MarketBeat
Tickers
ABBV
AZN
LLY
Exposures
Product Safety
Shareholders That Lost Money on Savara Inc. (SVRA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
October 23, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
SVRA
Exposures
Financial
Legal
Product Safety
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CYTK
October 23, 2025
Via
NewMediaWire
Topics
Earnings
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
Lost Money on aTyr Pharma, Inc. (ATYR)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
October 23, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
ATYR
Exposures
Financial
Legal
Product Safety
Shareholders That Lost Money on Savara Inc. (SVRA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
October 23, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Tickers
SVRA
Exposures
Financial
Legal
Product Safety
Cytokinetics, Incorporated Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CYTK
October 23, 2025
Via
TheNewswire.com
Topics
Earnings
Fraud
Lawsuit
Tickers
CYTK
Exposures
Financial
Legal
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.